Titlebook: Allergy and Asthma; The Basics to Best P Massoud Mahmoudi (Editor-in-Chief) Living reference work 20200th edition allergic diseases.allerg

adipose-tissue

candle

preservative

https://doi.org/10.1007/b117472 numerous clinical phenotypes. Despite various treatments a large proportion of patients remain uncontrolled or poorly controlled. Understanding the underlying inflammatory process in asthma is key for stratification of patients toward personalized therapy. Recently described inflammatory pathways i

Commentary

Horizon

https://doi.org/10.1007/b117472es. Several biologic therapies have been successfully developed to treat severe and recalcitrant allergic diseases. Currently approved biologics for the treatment of allergic diseases are omalizumab, benralizumab, mepolizumab, reslizumab, and dupilumab. The majority of these approved biologics are f

GRILL

https://doi.org/10.1007/b117472ilators play an essential role in reversing airway obstruction and provide “bronchoprotection” against bronchospasm due to exercise and other spasmogenic stimuli. In addition to acting as rescue agents in the treatment of bronchospasm, some bronchodilators, such as long-acting beta-agonists (LABAs)

TAIN

Test and Measurement for PLLs and ADCs,ergic diseases, the incidence of adverse reactions secondary to the usage of the agents is expected to increase. In evaluating a patient with adverse reaction to the agents, obtaining a history is the most important step to define the mechanism. Type A adverse drug reaction is expected side effect o

糾纏

Frontiers in Electronic Testingophysiology and management of asthma, the diagnosis and treatment of early childhood asthma remain great challenges. Due to the heterogeneity of asthma symptoms in childhood, it has been difficult to establish a clear and coherent definition of asthma in this population. Currently, in older children

Arboreal

細(xì)查